Author:
Khachanova N. V.,Gorokhova T. V.
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. T. Korn, T. Magnus, K. Toyka, and S. Jung, “Modulation of effector cell functions in experimental autoimmune encephalomyelitis by leflunomide-mechanisms independent of pyrimidine depletion,” J. Leukoc. Biol., 76, No. 5, 950–960 (2004).
2. M. Osiri, B. Shea, V. Robinson, et al., “Leflunomide for treating rheumatoid arthritis,” Cochrane Database of Systemic Reviews Online, CD002047.
3. J. Oh, and P. W. O’Connor, “Teriflunomide for the treatment of multiple sclerosis,” Seminars in Neurology, 33, No. 1, 45–55 (2013).
4. H. I. Keen, P. G. Conaghan, and S. E. Tett, “Safety evaluation of leflunomide in rheumatoid arthritis,” Expert Opin. Drug Saf., 12, No. 4, 581–588 (2013).
5. T. Leist, M. S. Freedman, L. Kappos, et al., “Pooled safety data from three placebo-controlled teriflunomide studies,” Mult. Scler., 19:74, 633 (2013).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献